Bausch Health Unit Signs LoI for Public Listing of Acne Gel Cabtreo in Canada

MT Newswires Live
04-09

Bausch Health's (BHC) Canada unit said Wednesday that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance for public drug plan coverage in Canada for its acne vulgaris treatment Cabtreo.

The company said the agreement allows Bausch Health Canada to finalize the listing of Cabtreo under individual government drug plans across Canada, including federal, provincial and territorial programs.

No financial terms of the agreement were disclosed.

Cabtreo has been approved by Health Canada as a triple-combination topical acne treatment, the company said.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10